[Event Report] Global Expert Meeting: “The Future of Health Technology Assessment” (September 12, 2018)
date : 9/27/2018
Tags: Future of the Health Care System, Innovation and Sustainability
![[Event Report] Global Expert Meeting: “The Future of Health Technology Assessment” (September 12, 2018)](https://hgpi.org/en/wp-content/uploads/sites/2/hta_0912_6-1.jpg)
HGPI convened the Global Expert Meeting “The Future of Health Technology Assessment”.
The creation of efficient and effective healthcare systems to ensure innovation and sustainability is a common issue for every country across the world, including Japan. Efforts are being made country by country to appropriately assess medical treatments. Health Technology Assessment (HTA) is one way to gauge the cost-effectiveness of healthcare systems and ensure the optimal allocation of resources. In Japan, since 2012 there have been many discussions held on the introduction of HTA, particularly at the Committee for Cost-Effectiveness Assessment within the Central Social Insurance Medical Council (Chuikyo). A trial introduction of Cost-Effectiveness Assessment started in FY2016. Dialogue on these assessments continues in FY2018 towards their full-scale introduction.
Since 2016, HGPI has conducted a series of expert meetings entitled “Rebalancing Healthcare Systems: Innovation and Sustainability” to facilitate open discussions on HTA. Throughout these meetings, we have worked to identify the issues and to provide policy recommendations.
Amidst ongoing considerations regarding the full-scale implementation of HTA and with discussions reaching a peak, HGPI organized this Global Expert Meeting to coincide with the ISPOR Asia Pacific Conference 2018 which was held in Tokyo. At this meeting, domestic and overseas experts joined in discussions not only on HTA as applied to pharmaceuticals, but also HTA within the field of medical devices, for which various approaches are being explored worldwide.
*For past activities, please refer to the “Activity Report – Special Edition on Innovation and Sustainability” (attached below).
■Overview
Explanatory Introduction
- Yuiko Kondo (Senior Associate, Health and Global Policy Institute)
Keynote Address 1 “HTA Experiences Overseas—Key Lessons Learned”
- Michael Drummond (Professor, Centre for Health Economics, University of York)
Keynote Address 2 “Introduction of HTA into the Medical Device Field in Europe—Status, Challenges, and Prospects”
- Rosanna Tarricone (Associate Dean, Government Health and Non Profit Division, SDA Bocconi School of Management / Associate Professor, Department of Social and Political Science, Bocconi University)
Keynote Address 3 “Efforts Aimed at Introducing HTA in Japan”
- Ataru Igarashi (Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
Panel Discussion “HTA in Japan—The Roles Required of Various Sectors”
Panelists:
- Ataru Igarashi
- Naomi Sakurai (President, Cancer Solutions Co., Ltd.)
- Yasushi Sakuramoto (Assistant Director, Medical Economics Division, Health Insurance Bureau, Ministry of Health, Labour and Welfare (MHLW))
- Koichi Nakao (President and Chief Executive Officer, Saiseikai Kumamoto Hospital)
- Rosanna Tarricone
Moderator:
- Makoto Tamura (Founder and CEO, Healthcare System Planning Institute / Research Professor, Graduate school of International University of Health and Welfare)
Closing Remarks
- Hiromi Mitsubayashi (Member of the House of Representatives)
(No particular order, titles omitted)
(Photographed by: Kazunori Izawa)
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)